Suppr超能文献

黄芪的抗衰老意义:一种著名的中国滋补品。

Anti-Aging Implications of (Huangqi): A Well-Known Chinese Tonic.

作者信息

Liu Ping, Zhao Haiping, Luo Yumin

机构信息

1Cerebrovascular Diseases Research Institute, and Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.

2Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China.

出版信息

Aging Dis. 2017 Dec 1;8(6):868-886. doi: 10.14336/AD.2017.0816. eCollection 2017 Dec.

Abstract

Owing to a dramatic increase in average life expectancy and the Family Planning program of the 1970s - 1990s, China is rapidly becoming an aging society. Therefore, the investigation of healthspan-extending drugs becomes more urgent. (Huangqi) is a major medicinal herb that has been commonly used in many herbal formulations in the practice of traditional Chinese medicine (TCM) to treat a wide variety of diseases and body disorders, or marketed as life-prolonging extracts for human use in China, for more than 2000 years. The major components of are polysaccharides, flavonoids, and saponins. Pharmacological research indicates that the extract component of can increase telomerase activity, and has antioxidant, anti-inflammatory, immunoregulatory, anticancer, hypolipidemic, antihyperglycemic, hepatoprotective, expectorant, and diuretic effects. A proprietary extract of the dried root of , called TA-65, was associated with a significant age-reversal effect in the immune system. Our review focuses on the function and the underlying mechanisms of in lifespan extension, anti-vascular aging, anti-brain aging, and anti-cancer effects, based on experimental and clinical studies.

摘要

由于平均预期寿命的急剧增加以及20世纪70年代至90年代的计划生育政策,中国正迅速步入老龄化社会。因此,对延长健康寿命药物的研究变得更加紧迫。黄芪是一种主要的草药,在传统中医实践中,它已被广泛用于许多草药配方中,用于治疗各种疾病和身体失调,在中国也作为延长寿命的提取物用于人类已有2000多年的历史。黄芪的主要成分是多糖、黄酮类化合物和皂苷。药理研究表明,黄芪提取物成分可增加端粒酶活性,并具有抗氧化、抗炎、免疫调节、抗癌、降血脂、降血糖、保肝、祛痰和利尿作用。一种名为TA - 65的黄芪干燥根的专利提取物在免疫系统中具有显著的逆龄效果。基于实验和临床研究,我们的综述重点关注黄芪在延长寿命、抗血管衰老、抗脑衰老和抗癌作用方面的功能及潜在机制。

相似文献

1
Anti-Aging Implications of (Huangqi): A Well-Known Chinese Tonic.
Aging Dis. 2017 Dec 1;8(6):868-886. doi: 10.14336/AD.2017.0816. eCollection 2017 Dec.
3
Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi).
Phytother Res. 2014 Sep;28(9):1275-83. doi: 10.1002/ptr.5188. Epub 2014 Aug 2.
4
Quality Analysis of Different Specification Grades of var. () from Hunyuan, Shanxi.
J AOAC Int. 2019 May 1;102(3):734-740. doi: 10.5740/jaoacint.18-0308.
9
Astragali radix (Huangqi): a time-honored nourishing herbal medicine.
Chin Med. 2024 Aug 30;19(1):119. doi: 10.1186/s13020-024-00977-z.
10
as a Drug Candidate for Inflammatory Bowel Disease: The Preclinical Evidence.
Am J Chin Med. 2023;51(6):1501-1526. doi: 10.1142/S0192415X23500684. Epub 2023 Aug 3.

引用本文的文献

2
Antioxidant action and potential neuroprotection of polyphenolics extracted from residue.
Front Nutr. 2025 Jul 23;12:1621848. doi: 10.3389/fnut.2025.1621848. eCollection 2025.
4
Immunometabolism and oxidative stress: roles and therapeutic strategies in cancer and aging.
NPJ Aging. 2025 Jul 1;11(1):59. doi: 10.1038/s41514-025-00250-z.
6
Bioactive components and clinical potential of species.
Front Pharmacol. 2025 May 16;16:1585697. doi: 10.3389/fphar.2025.1585697. eCollection 2025.
8
Natural Anti-aging Herb: Role and Potential of Astragalus membranaceus.
Chin J Integr Med. 2025 May 14. doi: 10.1007/s11655-025-4009-4.
9
Astragalus Membranaceus-Can It Delay Cellular Aging?
Nutrients. 2025 Apr 8;17(8):1299. doi: 10.3390/nu17081299.

本文引用的文献

2
Astragaloside IV Enhances Cisplatin Chemosensitivity in Human Colorectal Cancer via Regulating NOTCH3.
Oncol Res. 2016 Oct 27;24(6):447-453. doi: 10.3727/096504016X14685034103590.
3
Astragaloside II sensitizes human hepatocellular carcinoma cells to 5-fluorouracil via suppression of autophagy.
J Pharm Pharmacol. 2017 Jun;69(6):743-752. doi: 10.1111/jphp.12706. Epub 2017 Mar 7.
4
Therapeutic Effect of Astragalus Polysaccharides on Hepatocellular Carcinoma H22-Bearing Mice.
Dose Response. 2017 Jan 3;15(1):1559325816685182. doi: 10.1177/1559325816685182. eCollection 2017 Jan-Mar.
9
Astragaloside IV Enhances Cisplatin Chemosensitivity in Non-Small Cell Lung Cancer Cells Through Inhibition of B7-H3.
Cell Physiol Biochem. 2016;40(5):1221-1229. doi: 10.1159/000453175. Epub 2016 Dec 14.
10
Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling.
Int Immunopharmacol. 2017 Jan;42:195-202. doi: 10.1016/j.intimp.2016.10.001. Epub 2016 Dec 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验